scorecardresearch
Sunday, July 20, 2025
TopicIndia pharma industry

Topic: india pharma industry

India permits reopening of cough syrup firm linked to children’s deaths in Uzbekistan

The Marion factory in Uttar Pradesh was closed in March, after an analysis last year by Uzbekistan's health ministry of two cough syrups made by Marion, Ambronol and DOK-1 Max.

‘Need to transform India into high-value player’ — Centre launches national pharma R&D policy

Some of the key components of the policy include creating a regulatory environment that facilitates research, and incentivising private/public investment in innovation.

Uzbekistan says distributors of contaminated Indian cough syrup paid bribe to skip testing

The country put 21 people on trial - 20 of whom are Uzbeks and one Indian - over the deaths last week, making public for the first time a much higher death toll than previously reported.

WHO identifies batch of contaminated Indian cough syrup in Iraq

The batch, manufactured by Fourrts (India) Laboratories Pvt. Ltd for Dabilife Pharma Pvt. Ltd, had high levels of diethylene glycol and ethylene glycol, WHO said.

Trade body says Indian pharma exports to hit $27 billion this fiscal, despite cough syrup deaths

India is the world's third largest maker of drugs by volume, and US sales, which account for 30% of total pharma exports, have risen by 6.2% last year.

Govt suspends QP Pharma and 2 others’ licences over tainted cough syrup

India has tightened its testing of cough syrup exports since June, making it mandatory for companies to obtain a certificate of analysis from a govt lab before exporting products.

India to consider new bill for import, manufacture and sale of medicines

Recent cough syrup-related deaths and at least one other instance of an India-made eye drop being linked to 3 deaths in US, has cast a shadow on the industry’s image.

‘Does govt have the resources?’ Why pre-export testing of cough syrups may not plug all loopholes

Govt has made sample testing of cough syrups a must before export. Pharmaceutical analysts say this is a good move, but it may not be able to address all issues in drug quality management.

Manu Patolia built his $250 million empire with just 75 cents. Taravada Gurukul to New York

'From Village to the world' chronicles Manu Patolia's life journey from his humble background to the position of one of the industry leaders.

On Camera

Can Syria’s tiny Druze minority survive West Asia’s new storms? There’s little hope

Indians see West Asia as one uninterrupted wash of Islam, but the reality is more complex. For the Druze, support from Israel—where they are a recognised minority—is now critical.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.